Five challenges for bending the health care cost curve in Canada

 By Greg Marchildon and Livio Di Matteo Why health reform remains a challenge Canadian economists received a pleasant surprise this year: expenditure growth on public healthcare in Canada finally appears to be slowing down. However, it is unclear if this slowdown is the result of explicit success in sustainably bending the cost-curve

Ontario Spends More than $11 billion a Year on Prescription Drugs

 Why an income-based drug plan would not be good for Ontario’s economy or its seniors Ontario spends $11 billion per year on prescription drugs. Nearly half of this is spent on medicines used by senior citizens, a group that receives public subsidies for nearly all of their prescription drug costs

A New Paradigm for Cancer Prevention

 There have been several advances in the treatment of cancer over the last 20 years. We have new targeted oncology drugs with fewer side effects and improved technology allowing for more sensitive and earlier detection. Evolving research guides oncologists not only when to use chemotherapy, but more importantly, when not

ACE/Clear Defense Inc is proving a smashing point

 Peter Fabian likes to beat on a plate of glass now wand then with a baseball bat to see if he can shatter it. Sometimes, He'll even fire a bullet into it. The glass may crack, but it holds firm. Fabian is out to prove a smashing point.  Fabian is